Avalara Names Hugo Sarrazin Chief Executive Officer

Planned leadership transition positions Avalara to accelerate and scale its AI-driven innovation DURHAM,…

SEMIFIVE Showcases Advanced 3D-IC and Big Die Solutions for AI Semiconductor Innovation at SAFE™ Forum 2026

SAN JOSE, Calif., May 29, 2026 /PRNewswire/ — SEMIFIVE, a leading global…

Euhomy Helps Keep This Summer Chilled With Launch of Rock Plus and Rock Pro Smart Ice Makers

New tabletop ice makers deliver crystal-clear square and sphere ice for elevated…

DSC Holdings, AI Implementation Infrastructure for China's Used-Car Industry, Files for Nasdaq Listing

NEW YORK, May 29, 2026 /PRNewswire/ — The following report is from…

Hainan: A Microcosm of China's Opening Up

HAIKOU, China, May 29, 2026 /PRNewswire/ — A report from Hainan International Media…

WiMi Achieves Breakthrough in Deep Convolutional Neural Network Technology Based on Quantum Parameterized Circuits

BEIJING, May 29, 2026 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WiMi)…

Gastops FluidSIGHT™ Awarded IDEaS Test Drives Contract Under Canada's All Systems Go! Challenge

OTTAWA, ON, May 29, 2026 /PRNewswire/ — Gastops, a Canadian leader in…

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b…